CompaniesDBV Technologies
DBV Technologies logo

DBV Technologies

active
Châtillon, France
Founded 2002
Website
About

Epicutaneous immunotherapy for allergic desensitization

Areas of Focus

Categories

Small Molecule Pharmaceutical
Clinical Trials (19)
View all

Total Trials

19

As Lead Sponsor

17

As Collaborator

2

Total Enrollment

4,145

By Phase

PHASE3: 7PHASE2: 5PHASE1: 4PHASE1/PHASE2: 1

By Status

COMPLETED: 13UNKNOWN: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1NO_LONGER_AVAILABLE: 1AVAILABLE: 1
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Funding History (20)
8-K
Sep 18, 2025
8-K
Sep 5, 2025
8-K
Jul 29, 2025
8-K
Jun 25, 2025
8-K
Jun 11, 2025
DEF 14A
May 15, 2025
8-K
Apr 30, 2025
D
Apr 17, 2025
8-K
Mar 31, 2025
8-K
Mar 24, 2025
Locations (1)
Headquarters
Châtillon, France
Map

Loading map...